Home / NYT / A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12- to 15-year-olds.

A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12- to 15-year-olds.

Virual stuff May 12, 2021 NYT

By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/33B3aS4

A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12- to 15-year-olds.

A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12- to 15-year-olds.

Reviewed by Virual stuff on May 12, 2021 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )